Peptide Affinity Measurement
| Category | Research |
|---|---|
| Also known as | binding affinity measurement, Kd measurement peptide |
| Last updated | 2026-04-14 |
| Reading time | 3 min read |
| Tags | researchbindingmethodologybiophysics |
Overview
Binding affinity describes the strength of the interaction between a peptide and its receptor or other binding partner. It is typically expressed as a dissociation constant (Kd), the concentration at which half of the binding sites are occupied. Peptide-receptor Kd values range from picomolar (very strong) to micromolar (relatively weak), with most therapeutically interesting peptides showing affinities in the low nanomolar range.
Accurate affinity measurement is central to peptide pharmacology. It informs structure-activity relationship studies, supports medicinal chemistry optimization, and underlies the interpretation of functional and clinical data. Several complementary methods are used; each has distinct assumptions, advantages, and limitations.
For peptide drugs, affinity at the intended receptor is typically characterized alongside affinities at related receptors (for selectivity profiling) and at potential off-target receptors (for safety).
Common Methods
- Radioligand binding assay: Direct measurement using a radioactive tracer peptide and cell membranes expressing the receptor. Historically the gold standard.
- Fluorescent binding assays: Replace radioactive labels with fluorescent tags; often used in modern high-throughput screening.
- Surface plasmon resonance (SPR): Real-time kinetic measurement of binding and dissociation.
- Isothermal titration calorimetry (ITC): Measures heat evolved during binding, yielding affinity, stoichiometry, and thermodynamic parameters.
- Bio-layer interferometry (BLI): Similar to SPR, label-free real-time measurement.
- Fluorescence polarization (FP): Uses differences in rotational diffusion between bound and free fluorescent ligand.
- Fluorescence resonance energy transfer (FRET) assays: Distance-dependent energy transfer between donor and acceptor fluorophores.
Key Concepts
- Kd (dissociation constant): Concentration producing half-maximal occupancy.
- Ka (association constant): Reciprocal of Kd.
- kon and koff: Rate constants for association and dissociation.
- Scatchard analysis: Graphical transformation of equilibrium binding data.
- Cheng-Prusoff equation: Relates IC50 (from competition assays) to Ki (binding affinity of competitor).
- Nonspecific binding: Background binding to surfaces or non-receptor components, must be subtracted.
Background
The choice of affinity measurement method depends on the question being asked. Radioligand binding remains an excellent method for receptor pharmacology, particularly for GPCRs in cell membranes. Biophysical methods like SPR and ITC are preferred for purified proteins or well-defined systems, and can provide additional thermodynamic and kinetic information.
Understanding the residence time — how long a peptide remains bound before dissociating — has become an important consideration in addition to equilibrium affinity. Drugs with long residence times can produce sustained effects even when plasma concentrations fall, changing the relationship between PK and pharmacological action.
Practical Considerations
Affinity measurements must control for several variables:
- Buffer composition: pH, ionic strength, divalent cations.
- Temperature: Affinity and kinetics are temperature-dependent.
- Receptor preparation: Whole cells, membranes, purified receptor.
- Ligand stability: Peptides can degrade during long experiments.
- Specific versus nonspecific binding: Typically defined by addition of excess unlabeled ligand.
- Reporter orientation: Fluorescent or radioactive labels must not interfere with binding.
Modern Relevance
Affinity measurement is foundational to modern peptide drug discovery. Medicinal chemistry campaigns iterate through many analogs, measuring affinity at each step to guide further modifications. Biophysical methods allow detailed dissection of binding interactions, often combined with structural studies of the receptor-ligand complex.
Increasing attention is paid to the kinetics of binding — residence time, on- and off-rates — in addition to equilibrium affinity. Fast-on, slow-off profiles (long residence times) may produce more sustained pharmacology than rapid-equilibrium binding at the same Kd. For related concepts, see dissociation-constant, specificity-in-binding, and cross-reactivity.
Related Compounds
Related entries
- Dissociation Constant— The equilibrium concentration of free ligand at which half of the available binding sites are occupied — a direct and intuitive measure of binding strength.
- Cross-Reactivity in Peptide Research— Cross-reactivity describes the degree to which an antibody, receptor, or assay recognizes molecules other than its intended target.
- Dissociation Constant (Kd)— The dissociation constant (Kd) is the concentration at which half of a receptor's binding sites are occupied by a ligand, quantifying binding affinity.
- Specificity in Peptide Binding— Specificity describes the preference of a peptide for its intended receptor or target over structurally related alternatives.